NCT04076891: A trial that was reported late by Raziel Therapeutics Ltd.
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT04076891 |
|---|---|
| Title | An Open Label, Phase 2a Clinical Trial for the Evaluation of Safety and Efficacy of RZL-012 for the Treatment of Women With Lipedema Involving Substantial Fat Above the Knee or of Women and Men With Nodular Dercum's Disease |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 28, 2018 |
| Completion date | May 2, 2019 |
| Required reporting date | May 1, 2020, midnight |
| Actual reporting date | Dec. 19, 2023 |
| Date last checked at ClinicalTrials.gov | April 26, 2024 |
| Days late | 1453 |